Brain-Computer Interface: From Experimental Cutting-Edge Technology to Large-Scale Implementation, Opportunities and Challenges Coexist
03/01/2026
I. Introduction: Brain-Computer Interfaces on the Eve of Mass Production
December 31, 2025, Musk announced significant news via the X platform, clearly stating that his brain-computer interface company Neuralink will commence large-scale mass production of devices in 2026 and implement a highly streamlined, almost fully automated surgical procedure. This news, reported by global authoritative media such as Reuters and Business Insider, quickly caused a stir in the industry, marking a critical juncture where brain-computer interface technology officially transitions from the experimental phase to commercial mass production preparation. December 31, 2025, Musk announced significant news via the X platform, clearly stating that his brain-computer interface company Neuralink will commence large-scale mass production of devices in 2026 and implement a highly streamlined, almost fully automated surgical procedure. This news, reported by global authoritative media such as Reuters and Business Insider, quickly caused a stir in the industry, marking a critical juncture where brain-computer interface technology officially transitions from the experimental phase to commercial mass production preparation.
Currently, brain-computer interfaces have become a core arena for global tech giants and research institutions to compete in, with Elon Musk's Neuralink, Sam Altman's investment in Murts Labs, and others actively making strategic moves. From medical rehabilitation to human-machine symbiosis, from technological breakthroughs to ethical questioning, brain-computer interfaces are not only reshaping the relationship between humanity and technology but may also redefine the very form of existence for life. Currently, brain-computer interfaces have become a core arena for global tech giants and research institutions to compete in, with Elon Musk's Neuralink, Sam Altman's investment in Murts Labs, and others actively making strategic moves. From medical rehabilitation to human-machine symbiosis, from technological breakthroughs to ethical questioning, brain-computer interfaces are not only reshaping the relationship between humanity and technology but may also redefine the very form of existence for life.
II. Technical Foundation: The Game of Two Paths and Core Evaluation Dimensions
Core Principle: The Signal Bridge Between the Brain and Machines
Brain-Computer Interface (BCI) is essentially a bridge connecting the brain to external machines. The human brain consists of approximately 86 billion neurons, where all thoughts and actions transmit information through neuronal firing. The core task of a brain-computer interface is to read (decode) and write (encode) these neural electrical signals, enabling interaction between thoughts and external devices. Currently, this technology can already read brain signals from paralyzed patients, decode them, and achieve basic applications such as controlling a mouse, playing games, or operating a robotic arm to grasp objects.
Divergence in Technical Approaches: Invasive vs. Non-Invasive
Currently, brain-computer interface technology is primarily divided into two major pathways, each with its own strengths and weaknesses in terms of safety, signal quality, and application scenarios, creating a distinct competitive landscape.
Invasive Brain-Computer Interface is represented by Neuralink. Its core method involves creating a coin-sized opening in the skull, penetrating the skin, skull, and dura mater to insert electrodes finer than a human hair directly into the cerebral cortex to collect signals. The significant advantage of this approach is high signal quality, as the electrodes can make direct contact with neurons; however, its drawbacks are equally prominent, being invasive and carrying surgical risks and long-term biocompatibility issues. Invasive Brain-Computer Interface is represented by Neuralink. Its core method involves creating a coin-sized opening in the skull, penetrating the skin, skull, and dura mater to insert electrodes finer than a human hair directly into the cerebral cortex to collect signals. The significant advantage of this approach is high signal quality, as the electrodes can make direct contact with neurons; however, its drawbacks are equally prominent, being invasive and carrying surgical risks and long-term biocompatibility issues.
(Semi) Non-Invasive Brain-Computer Interface is represented by the ultrasound technology adopted by Murts Labs, in which Sam Altman has invested. It does not require insertion into the brain, being completely non-invasive or only semi-invasive (not penetrating the dura mater). It utilizes ultrasound to collect blood flow signals around neurons during their activity (neural activity requires blood supply). Its greatest advantage is minimal damage to the brain, with the difficulty of semi-invasive surgery comparable to picking one's nose; however, the core challenge lies in the 0.5 - 1.5 second delay between blood flow signals and neural electrical signals, making decoding more difficult.
Key evaluation dimension: Resolution determines the level of technological advancement.
There are two core dimensions for evaluating the development level of brain-computer interfaces: one is spatial resolution, which refers to the number of neurons that can be monitored; the other is temporal resolution, which refers to the frequency of capturing neuron discharges per second, requiring monitoring standards at the microsecond level. There are two core dimensions for evaluating the development level of brain-computer interfaces: one is spatial resolution, which refers to the number of neurons that can be monitored; the other is temporal resolution, which refers to the frequency of capturing neuron discharges per second, requiring monitoring standards at the microsecond level.
From the current technological comparison, Neuralink's invasive approach has achieved a time resolution of 10 microseconds. In terms of spatial resolution, with 64 electrode threads and 1024 contact points, it can capture signals from approximately 2000 neurons in total. However, its limitations are significant. Compared to the total of 86 billion neurons, 2000 is merely a drop in the ocean. The detection area only covers about 1.3/1000 of the brain's surface area, and the insertion depth is only 3-5 millimeters (the brain's depth is approximately 80 millimeters). In contrast, the non-invasive approach of ultrasonic brain-computer interfaces holds an advantage in spatial coverage. Theoretically, one probe can cover 1/4 of the brain, and four probes can achieve full coverage. However, its shortcomings, such as poor time resolution and a signal delay of about 1 second, are difficult to overlook.
III. Global Competition: Mass Production Ambitions and Technological Breakthroughs
From technological breakthroughs to large-scale implementation.
Since its establishment in 2016, Neuralink has undergone nearly a decade of development, with its valuation exceeding $9 billion, a team size of nearly 300 people, and has completed the full cycle of hardware development, chip iteration, animal experiments, and human clinical trials. The core support for its 2026 mass production plan is a series of technological breakthroughs and milestone achievements. Since its establishment in 2016, Neuralink has undergone nearly a decade of development, with its valuation exceeding $9 billion, a team size of nearly 300 people, and has completed the full cycle of hardware development, chip iteration, animal experiments, and human clinical trials. The core support for its 2026 mass production plan is a series of technological breakthroughs and milestone achievements.
Core Technical Parameters: Neuralink's implant chip is the N1 chip, measuring approximately 23mm×8mm (the size of a coin). It integrates 1024 electrode channels, each capable of independently collecting neuronal firing signals. The electrodes are distributed across 64 flexible threads, each 20 times thinner than a human hair. The accompanying R1 surgical robot possesses micron-level operational precision and can insert electrodes into specified locations at a speed of six threads per minute while avoiding dense brain blood vessels. Core Technical Parameters: Neuralink's implant chip is the N1 chip, measuring approximately 23mm×8mm (the size of a coin). It integrates 1024 electrode channels, each capable of independently collecting neuronal firing signals. The electrodes are distributed across 64 flexible threads, each 20 times thinner than a human hair. The accompanying R1 surgical robot possesses micron-level operational precision and can insert electrodes into specified locations at a speed of six threads per minute while avoiding dense brain blood vessels.
Latest Surgical Breakthrough: Electrode wires can directly penetrate the dura mater without resection, which Musk calls a major breakthrough. The new generation of surgical robots has reduced the single implantation time from 17 seconds to 1.5 seconds, and the entire procedure can be completed within 1 hour. The goal is to achieve fully automated outpatient surgery-level operations in the future, without the need for surgeons.
Clinical Trial Progress: As of late 2025 to early 2026, approximately 12-20 patients have received the device implant (Musk mentioned close to 20). The participants primarily include patients with severe paralysis, ALS, and similar conditions. Early patients, such as the first recipient Noland Arbaugh, have been using the device for over 21 months, with stable and continuously improving functionality. Some patients can now control computer cursors, type, play games, browse the web, post on social media, and even operate robotic arms to perform physical actions like eating and grasping objects through thought. Furthermore, some patients have begun taking university courses, delivering speeches, or using CAD software again to design parts, enabling them to work from home.Clinical Trial Progress: As of late 2025 to early 2026, approximately 12-20 patients have received the device implant (Musk mentioned close to 20). The participants primarily include patients with severe paralysis, ALS, and similar conditions. Early patients, such as the first recipient Noland Arbaugh, have been using the device for over 21 months, with stable and continuously improving functionality. Some patients can now control computer cursors, type, play games, browse the web, post on social media, and even operate robotic arms to perform physical actions like eating and grasping objects through thought. Furthermore, some patients have begun taking university courses, delivering speeches, or using CAD software again to design parts, enabling them to work from home.
Three-Step Roadmap (2026-2028): Step One, Telepathy, is currently underway, enabling spinal cord injury patients to control devices such as phones and computers with their minds, completing the commercialization loop; Step Two, Blindsight, a key focus for 2026, involves bypassing the eyes to encode images captured by a camera into electrical signals directly input into the brain's visual cortex, restoring vision and even enabling infrared/ultraviolet/radar vision; Step Three, Deep, targets deep brain areas to treat conditions like depression and Parkinson's disease, touching upon the core domains of human emotion and consciousness regulation.
Milestone Achievements in 2025: Completed the first implantations in the Middle East/UK/Canada, obtained FDA Breakthrough Device Designation for speech restoration, secured $650 million in financing, significantly improved the precision of the new-generation surgical robot, and laid the foundation for mass production in 2026. Milestone Achievements in 2025: Completed the first implantations in the Middle East/UK/Canada, obtained FDA Breakthrough Device Designation for speech restoration, secured $650 million in financing, significantly improved the precision of the new-generation surgical robot, and laid the foundation for mass production in 2026.
IV. Current Limitations: Multiple Gaps Remain Before Achieving "Consciousness Immortality"
Despite the rapid advancements in brain-computer interface technology, current capabilities still have significant limitations, and there remains a long distance from the long-term vision of consciousness immortality.
Signal Reading: Only able to "eavesdrop" on sporadic instructions.
If we compare the brain to a command center with 86 billion staff members, current brain-computer interfaces are like poorly-signaled eavesdropping devices placed in a corner, capable of only catching scattered words (such as "raise hand" or "move") from a few dozen nearby, loud-voiced staff members. These words are then used to infer intentions and control external devices. Their applications remain limited to helping paralyzed patients improve their quality of life and cannot achieve more complex conscious interactions.
Signal Writing: Far from Achieving "Knowledge Upload"
Current technology is far from capable of uploading knowledge or memories directly to the brain as depicted in science fiction films. There are three core reasons: first, insufficient resolution makes it impossible to decode complex consciousness and memories; second, the unique structure of the brain employs a memory-computation integrated model, where consciousness and memories result from the combined activity of multiple brain regions, not encoding by a single area; third, human understanding of how the brain works is still less than 1%. Current applications of writing are limited to stimulating neurons in specific known brain regions through electrical or ultrasonic means, used for treating neurological disorders such as pain, insomnia, Alzheimer's disease, stroke, and epilepsy.
Personalized Challenge: Individual Differences in Signal Encoding.
Brain-computer interfaces exhibit highly personalized characteristics, with each individual's brain signal encoding methods being completely different. For example, the same signal may represent leg kicking in person A's brain, while in person B's brain it may represent drinking water. Therefore, subjects require long-term training after surgery to allow machine learning to adapt to their unique signal patterns, enabling effective control, which also increases the difficulty of widespread technology adoption.
V. Future Prospects: The Integrated Vision of Brain-Computer Interface and Embodied Intelligence
The future development of brain-computer interfaces hinges on technological integration, specifically the synergistic advancement of brain-computer interfaces + artificial intelligence (rapid decoding) + **embodied intelligence (manipulating the physical world)**. Industry predictions suggest that in the more distant future (e.g., 30 years from now), achieving the following breakthroughs may unlock entirely new possibilities for consciousness continuation: observing every action and discharge of all 86 billion neurons, fully understanding the brain's working mechanisms, and achieving consciousness carrier transfer.
This form of consciousness carrier transfer may manifest in two ways: first, transferring memories and consciousness into a robot to continue thinking and playing the role of a human; second, like grafting, connecting the central nervous system to new carriers such as bionic bodies through brain-computer interfaces to continue living. Musk further proposes the ultimate goal: achieving a full-brain interface, increasing the number of electrodes to more than 25,000, enabling direct connection between the human brain and the cloud, bridging the vast gap between human language output bandwidth (tens of bits per second) and AI data throughput (trillions of bits per second), and preventing humans from losing competitiveness in the future.
From a short-term perspective, 2026 will be a pivotal year for the advancement of brain-computer interface technology: Neuralink's Blind Sight project is expected to initiate its first patient trials, with Musk expressing strong confidence in restoring full body motor functions (animal experiments have been completed, and human validation is about to begin); clinical trials worldwide will further expand in scale, and the safety and efficacy of the technology will undergo more validation.
VI. Ethical and Social Challenges: Questioning Boundaries in the Rapid Advancement of Technology
Brain-computer interfaces, while driving human progress, also bring a series of ethical and social challenges, becoming an unavoidable core issue. Brain-computer interfaces, while driving human progress, also bring a series of ethical and social challenges, becoming an unavoidable core issue.
Risk of Social Division: Death Equity and Intelligence Gap
If brain-computer interface technology advances further, it may break the last fair line of defense for humanity—death. In the process of its popularization, if high-end brain plugins that enhance memory and computational power emerge and are expensive, it will lead to a wealth gap in intelligence, creating an insurmountable divide. The idea that knowledge changes fate could be distorted into "recharging to change species."
Privacy and the Crisis of Free Will: The Risks of Datafying Thought
When the brain is directly connected to the internet, thoughts, memories, and dreams will become data streams that can be stored and analyzed. This brings two core risks: first, security risks, where hackers may invade the brain, and if the device is infected with a virus or attacked, humans may crash or be controlled by AI; second, commercial alienation and manipulation of free will, where commercial companies may implant advertisements or suggestions into the subconscious, manipulating human desires and choices, completely undermining the foundation of free will.
Controversies in Technology Ethics: Experimental Costs and the Pace of Development
Neuralink's development journey has been marked by numerous ethical controversies: According to reports, since 2018, in animal experiments involving pigs, sheep, monkeys, and others, issues such as chip fractures, intracranial infections, and cerebral cortex damage have led to the deaths of at least 1500 animals; malfunctions have also occurred in human trials, where the first patient, Noland Arbaugh, experienced partial electrode retraction within weeks after surgery, causing the chip to fail, and the fourth patient exhibited implant rejection and even reported suicidal tendencies. Furthermore, of the eight scientists at the company's inception, only two remained by 2022. Those who left believed that scientific development should proceed step by step, while the company's set timeline was too aggressive. Neuralink's development journey has been marked by numerous ethical controversies: According to reports, since 2018, in animal experiments involving pigs, sheep, monkeys, and others, issues such as chip fractures, intracranial infections, and cerebral cortex damage have led to the deaths of at least 1500 animals; malfunctions have also occurred in human trials, where the first patient, Noland Arbaugh, experienced partial electrode retraction within weeks after surgery, causing the chip to fail, and the fourth patient exhibited implant rejection and even reported suicidal tendencies. Furthermore, of the eight scientists at the company's inception, only two remained by 2022. Those who left believed that scientific development should proceed step by step, while the company's set timeline was too aggressive.
The Original Intent of Technology: The Warmth of Life's Continuation
The perspective of ALS patient and former JD.com Vice President Cai Lei reveals the warm undertone of technology: to liberate life from the constraints of the physical body, allowing love and attachment to continue in a more enduring way. This also reminds the industry that discussing the essence of consciousness immortality and human-machine coexistence is not about breaking the fairness of death, but about endowing life with new possibilities and continuity. Technological development must adhere to the bottom line of humanistic care. The perspective of ALS patient and former JD.com Vice President Cai Lei reveals the warm undertone of technology: to liberate life from the constraints of the physical body, allowing love and attachment to continue in a more enduring way. This also reminds the industry that discussing the essence of consciousness immortality and human-machine coexistence is not about breaking the fairness of death, but about endowing life with new possibilities and continuity. Technological development must adhere to the bottom line of humanistic care.
VII. Conclusion: Standing at the Threshold of an Era Redefining Humanity
2026 is highly likely to be the year when Neuralink transitions from experimental cutting-edge technology to a scalable medical product, and it will also become a critical milestone in the global competition for brain-computer interface technology. Musk's mass-production plan and vision of human-machine symbiosis are accelerating their realization, securing a significant position in the global technology race.
We are standing on the threshold of an era transitioning from repairing humans to enhancing humans, and potentially redefining humanity. Regarding brain-computer interface technology, we should maintain reverence but not resistance—technology itself is neither good nor evil; the key lies in those who wield it. In the future, it is essential to prioritize the establishment of rules for brain-related technologies, preventing the digital world from becoming a cyber playground for the few and a digital prison for the many, ensuring that technology truly serves the continuation of life and the enhancement of well-being for all humanity.